These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12591099

  • 21. Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex.
    Devoto P, Flore G, Saba P, Scheggi S, Mulas G, Gambarana C, Spiga S, Gessa GL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar 02; 90():97-103. PubMed ID: 30472147
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions.
    Garris PA, Ciolkowski EL, Wightman RM.
    Neuroscience; 1994 Mar 02; 59(2):417-27. PubMed ID: 8008199
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cocaine increases stimulated dopamine release more in periadolescent than adult rats.
    Walker QD, Kuhn CM.
    Neurotoxicol Teratol; 2008 Mar 02; 30(5):412-8. PubMed ID: 18508233
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of L-dopa on in vitro dopamine release from striatum.
    Snyder GL, Zigmond MJ.
    Brain Res; 1990 Feb 05; 508(2):181-7. PubMed ID: 2106362
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep 05; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 05; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 34. Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum.
    Maeda T, Kannari K, Suda T, Matsunaga M.
    Brain Res; 1999 Jan 30; 817(1-2):185-91. PubMed ID: 9889362
    [Abstract] [Full Text] [Related]

  • 35. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS, Fisher A, Starr MS.
    Synapse; 1998 Nov 30; 30(3):309-17. PubMed ID: 9776134
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ethanol modulates evoked dopamine release in mouse nucleus accumbens: dependence on social stress and dose.
    Yavich L, Tiihonen J.
    Eur J Pharmacol; 2000 Aug 11; 401(3):365-73. PubMed ID: 10936495
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM, Connick JH.
    Eur J Pharmacol; 1998 Dec 04; 362(2-3):127-36. PubMed ID: 9874162
    [Abstract] [Full Text] [Related]

  • 40. The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K, Voehringer P, Ferger B.
    J Neurochem; 2010 Jan 04; 112(2):444-52. PubMed ID: 19895663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.